Summary
A small Allendale company has received an important patent for its development of stem cell therapy for heart attack patients.
The company showed in a small study last year that stem cells taken from a patient's bone marrow, when specially prepared and injected back into the patient via the heart's damaged blood vessel, help repair the injured heart muscle and cause new blood vessels to grow.See the full content of this document
Extract
Stem Cell Treatment Patent Approved
Based on those results, Amorcyte Inc. received Patent No. 7,794,705, which it calls "the first U.S. patent in the industry to fully enable practical development of stem cell therapies for treating heart damage following a heart ...
See the full content of this document
Sponsored links
